Login Register Cart 0
Generic placeholder image

Current Respiratory Medicine Reviews

Editor-in-Chief

ISSN (Print): 1573-398X
ISSN (Online): 1875-6387

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Case Report

Influence of Lung Hyperinflation on Respiratory Muscles Pressures During a Submaximal Test in Patients With COPD: A Clinical Perspective

Author(s): Elias F. Porto*, Sabrina Clares, Ana M.J. Ferracioli, Marcio R.P. de Sousa, José Renato de Oliveira Leite, Rafael T. Malheiros and Antonio A.M. De Castro*

Volume 16, Issue 3, 2020

Page: [201 - 206] Pages: 6

DOI: 10.2174/1573398X16999201026222938

Price: $65

conference banner
Abstract

Background and Objective: Reduction of exercise tolerance is associated with expiratory flow-limitation (EFL) and lung hyperinflation; those are only partially reversible to bronchodilator. Lung hyperinflation lowers the diaphragm muscle provoking a mechanical disadvantage that, eventually, reduces maximal inspiratory (MIP) and expiratory (MEP) pressures. We aimed to assess the influence of the dynamic lung hyperinflation on respiratory pressures changes at rest and after a submaximal exercise test in COPD patients with and without a bronchodilator.

Methods: We prospectively analyzed 16 COPD patients (FEV1 36.4±10% pred.; age 61.0±8 years, height 165±12 cm and BMI 25.9±6 kg/m2). MIP and MEP were measured before and after performing the six minutes walking test (6MWT) with and without bronchodilator (400 mcg of albuterol).

Results: Nine of 16 patients increased IC more than 150 ml after bronchodilator use. Right after the 6MWT was accomplished without bronchodilator, IC decreased by 7.05% as compared to the 6MWT baseline value (p<0.01). Nine patients decreased IC more than 150ml. After bronchodilator use, patients performed the 6MWT without any IC significant reduction (p>0.05). Twelve patients increased the MIP (ranging from 70±11cmH2O to 77±10cmH2O, p = 0.0043) using 400mcg of albuterol. Thirteen patients reduced MIP after the 6MWT without bronchodilator use (p <0.007). There was no significant reduction (p> 0.05) in MIP when patients performed the 6MWT after bronchodilator use. We also found a significant correlation between MIP and inspiratory capacity (IC) and MEP and the IC before and after the 6MWT (r=0.61, p=0.0054; r=0.60, p=0.0031, respectively).

Conclusion: Dynamic pulmonary hyperinflation directly interferes with the ability of respiratory muscles to generate inspiratory and expiratory pressures. The previous use of bronchodilators in patients with COPD reduced dynamic hyperinflation when accomplishing a sub-maximal exercise.

Keywords: COPD, lung hyperinflation, respiratory muscles, 6MWT, bronchodilator, dynamic pulmonary.

« Previous
Graphical Abstract

[1]
Sievi NA, Brack T, Brutsche MH, et al. Physical activity declines in COPD while exercise capacity remains stable: A longitudinal study over 5 years. Respir Med 2018; 141: 1-6.
[http://dx.doi.org/10.1016/j.rmed.2018.06.013] [PMID: 30053953]
[2]
Mirza S, Clay RD, Koslow MA, Scanlon PD. COPD guidelines: a review of the 2018 GOLD report.InMayo Clinic Proceedings. Elsevier 2018; 93: pp. (1)1488-502.
[3]
O’Donnell DE, Webb KA. The major limitation to exercise performance in COPD is dynamic hyperinflation. J Appl Physiol 2008; 105(2): 753-5.
[http://dx.doi.org/10.1152/japplphysiol.90336.2008b] [PMID: 18678624]
[4]
Sliwinski P, Kaminski D, Zielinski J, Yan S. Partitioning of the elastic work of inspiration in patients with COPD during exercise. Eur Respir J 1998; 11(2): 416-21.
[http://dx.doi.org/10.1183/09031936.98.11020416] [PMID: 9551747]
[5]
O’donnell DE, Laveneziana P. Physiology and consequences of lung hyperinflation in COPD. Eur Respir Rev 2006; 15(100): 61-7.
[http://dx.doi.org/10.1183/09059180.00010002]
[6]
Dodd DS, Brancatisano T, Engel LA. Chest wall mechanics during exercise in patients with severe chronic air-flow obstruction. Am Rev Respir Dis 1984; 129(1): 33-8.
[PMID: 6230971]
[7]
Porto EF, Castro AA, Velloso M, Nascimento O, Dal Maso F, Jardim JR. Exercises using the upper limbs hyperinflate COPD patients more than exercises using the lower limbs at the same metabolic demand. Monaldi Arch Chest Dis 2009; 71(1): 21-6.
[PMID: 19522161]
[8]
Sharp JT, Danon J, Druz WS, Goldberg NB, Fishman H, Machnach W. Respiratory muscle function in patients with chronic obstructive pulmonary disease: its relationship to disability and to respiratory therapy. American Rev Res Dis 1974; 110(6P2): 154-67.
[9]
Porto EF, Castro AA, Nascimento O, Oliveira RC, Cardoso F, Jardim JR. Modulation of operational lung volumes with the use of salbutamol in COPD patients accomplishing upper limbs exercise tests. Respir Med 2009; 103(2): 251-7.
[http://dx.doi.org/10.1016/j.rmed.2008.08.018] [PMID: 18930646]
[10]
American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152(5 Pt 2): S77-S121.
[PMID: 7582322]
[11]
McConnell AK, Copestake AJ. Maximum static respiratory pressures in healthy elderly men and women: issues of reproducibility and interpretation. Respiration 1999; 66(3): 251-8.
[http://dx.doi.org/10.1159/000029386] [PMID: 10364742]
[12]
McElvaney G, Blackie S, Morrison NJ, Wilcox PG, Fairbarn MS, Pardy RL. Maximal static respiratory pressures in the normal elderly. Am Rev Respir Dis 1989; 139(1): 277-81.
[http://dx.doi.org/10.1164/ajrccm/139.1.277] [PMID: 2912349]
[13]
Larson JL, Kim MJ. Reliability of maximal inspiratory pressure. Nurs Res 1987; 36(5): 317-9.
[http://dx.doi.org/10.1097/00006199-198709000-00015] [PMID: 3650806]
[14]
Neder JA, Andreoni S, Lerario MC, Nery LE. Reference values for lung function tests. II. Maximal respiratory pressures and voluntary ventilation. Braz J Med Biol Res 1999; 32(6): 719-27.
[http://dx.doi.org/10.1590/S0100-879X1999000600007] [PMID: 10412550]
[15]
ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166(1): 111-7.
[http://dx.doi.org/10.1164/ajrccm.166.1.at1102] [PMID: 12091180]
[16]
Redelmeier DA, Bayoumi AM, Goldstein RS, Guyatt GH. Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients. Am J Respir Crit Care Med 1197; 155(4): 1278-82.
[http://dx.doi.org/10.1164/ajrccm.155.4.9105067]
[17]
Taube C, Lehnigk B, Paasch K, Kirsten DK, Jörres RA, Magnussen H. Factor analysis of changes in dyspnea and lung function parameters after bronchodilation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 162(1): 216-20.
[http://dx.doi.org/10.1164/ajrccm.162.1.9909054] [PMID: 10903244]
[18]
Hatipoğlu U, Laghi F, Tobin MJ. Does inhaled albuterol improve diaphragmatic contractility in patients with chronic obstructive pulmonary disease? Am J Respir Crit Care Med 1999; 160(6): 1916-21.
[http://dx.doi.org/10.1164/ajrccm.160.6.9903122] [PMID: 10588606]
[19]
O’Donnell DE, Lam M, Webb KA. Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158(5 Pt 1): 1557-65.
[http://dx.doi.org/10.1164/ajrccm.158.5.9804004] [PMID: 9817708]
[20]
Cortopassi F, Castro AAM, Porto EF, et al. Comprehensive exercise training improves ventilatory muscle function and reduces dyspnea perception in patients with COPD. Monaldi Arch Chest Dis 2009; 71(3): 106-12.
[PMID: 19999956]
[21]
Colucci M, Cortopassi F, Porto E, et al. Upper limb exercises using varied workloads and their association with dynamic hyperinflation in patients with COPD. Chest 2010; 138(1): 39-46.
[http://dx.doi.org/10.1378/chest.09-2878] [PMID: 20202941]
[22]
Permadi AW, Putra IMWA. Comparison of respiratory training methods for chest wall expansion in patients with chronic obstructive pulmonary disease. J Phys Educ Sport 2018; 18(4): 2235-9.
[23]
Aquino ES, Mourão FA, Souza RK, Glicério BM, Coelho CC. Comparative analysis of the six-minute walk test in healthy children and adolescents Rev Bras Fisioter 2010; 14(1): 75-80.
[http://dx.doi.org/10.1590/S1413-35552010000100012] [PMID: 20414565]
[24]
Beriault K, Carpentier AC, Gagnon C, et al. Reproducibility of the 6-minute walk test in obese adults. Int J Sports Med 2009; 30(10): 725-7.
[http://dx.doi.org/10.1055/s-0029-1231043] [PMID: 19585400]
[25]
Holland AE, Hill CJ, Rasekaba T, Lee A, Naughton MT, McDonald CF. Updating the minimal important difference for six-minute walk distance in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil 2010; 91(2): 221-5.
[http://dx.doi.org/10.1016/j.apmr.2009.10.017] [PMID: 20159125]
[26]
McKenzie DK, Butler JE, Gandevia SC. Respiratory muscle function and activation in chronic obstructive pulmonary disease. J Appl Physiol 2009; 107(2): 621-9.
[http://dx.doi.org/10.1152/japplphysiol.00163.2009] [PMID: 19390004]
[27]
Dos Santos K, Gulart AA, Munari AB, Cani KC, Mayer AF. Reproducibility of ventilatory parameters, dynamic hyperinflation, and performance in the Glittre-ADL TEST in COPD patients. COPD 2016; 13(6): 700-5.
[http://dx.doi.org/10.1080/15412555.2016.1177007] [PMID: 27163407]

Rights & Permissions Print Cite
Article Metrics
12
Wayfinder Image
World Pneumonia Day
© 2024 Bentham Science Publishers | Privacy Policy